William F. Doyle
CIK: 0001194459
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 28, 2026PROK
PROKIDNEY CORP.
Award(A)DirectDirector stock option (right to buy)
135K shares- - Mar 3, 2026NVCR
NovoCure Ltd
Award(A)Direct200.3K shares- - Mar 3, 2026NVCR
NovoCure Ltd
Sale(S)Direct50.6K shares at avg. $12.79$646K - Mar 3, 2026NVCR
NovoCure Ltd
Award(A)Direct200K shares- - Mar 3, 2026NVCR
NovoCure Ltd
Sale(S)Direct21.3K shares at avg. $13.43$286K - May 29, 2025PROK
PROKIDNEY CORP.
Award(A)DirectDirector stock option (right to buy)
125.9K shares- - Nov 29, 2024ELAN
Elanco Animal Health Inc
Award(A)Direct18.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2026 |  PROK PROKIDNEY CORP. | Award(A) Director stock option (right to buy) | 135,000 | - | - | Direct |
| Mar 3, 2026 |  NVCR NovoCure Ltd | Award(A) | 200,284 | - | $0 | Direct |
| Mar 3, 2026 | NVCR NovoCure Ltd | Sale(S) | 50,557 | $12.79 | $646,447 | Direct |
| Mar 3, 2026 | NVCR NovoCure Ltd | Award(A) | 200,000 | - | $0 | Direct |
| Mar 3, 2026 | NVCR NovoCure Ltd | Sale(S) | 21,330 | $13.43 | $286,436 | Direct |
| May 29, 2025 | PROK PROKIDNEY CORP. | Award(A) Director stock option (right to buy) | 125,862 | - | - | Direct |
| Nov 29, 2024 |  ELAN Elanco Animal Health Inc | Award(A) | 18,169 | - | $0 | Direct |
1-7 of 7 transactions
About DOYLE WILLIAM F
DOYLE WILLIAM F (SEC CIK 0001194459) files insider reports with the SEC as Director of PROKIDNEY CORP. (PROK), Executive Chairman of NovoCure Ltd (NVCR) and Director of Elanco Animal Health Inc (ELAN).
Signal8 holds 4 ownership filings by DOYLE WILLIAM F, all Form 4s, filed between Dec 3, 2024 and May 29, 2026. Those filings report 7 transactions, from Nov 29, 2024 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DOYLE WILLIAM F's filings is in WAYNE, PA.
Recent filings by DOYLE WILLIAM F
- May 28, 2026: Grant or award of PROK derivative securities (Form 4, code A).
- Mar 3, 2026: Grant or award of NVCR shares (Form 4, code A).
- Mar 3, 2026: Open-market sale of NVCR shares (Form 4, code S).
- Mar 3, 2026: Grant or award of NVCR shares (Form 4, code A).
- Mar 3, 2026: Open-market sale of NVCR shares (Form 4, code S).
Other insiders filing for PROKIDNEY CORP. (PROK)
- Weber Darin J., Chief Regulatory Officer
- Pereira Brian JG, Director
- Locke Kenneth Thomas, Chief Technical Officer
- Girolamo Todd C, Chief Legal Officer
- Lotvin Alan, Director
- Jimenez Santos Jose Ignacio, Director